These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8625541)

  • 41. Hepatitis B virus blood screening: unfinished agendas.
    Comanor L; Holland P
    Vox Sang; 2006 Jul; 91(1):1-12. PubMed ID: 16756595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
    Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
    Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Theoretical and technical concerns in inactivation/elimination of viruses in plasma derivatives.
    Hilfenhaus J; Niedrig M; Nowak T
    Dev Biol Stand; 1993; 81():117-23. PubMed ID: 8174794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous immunoglobulins: clinical experience and viral safety.
    Ballow M
    J Am Pharm Assoc (Wash); 2002; 42(3):449-58; quiz 458-9. PubMed ID: 12030632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical experience with the viral safety of immunoglobulins.
    Hellstern P
    Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 3():S31-4; discussion S35. PubMed ID: 7749046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virus inactivation procedures: an overview.
    Tedder R
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S13-4. PubMed ID: 7495960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Requirements for safety and quality of intravenous immunoglobulin G preparations.
    Rütter GH
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):2-5. PubMed ID: 7964845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adverse reactions and pathogen safety of intravenous immunoglobulin.
    Carbone J
    Curr Drug Saf; 2007 Jan; 2(1):9-18. PubMed ID: 18690945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Side effects and risk factors of various plasma donation methods].
    Ullrich H; Wiebecke D; Keller F
    Beitr Infusionsther; 1991; 28():77-81. PubMed ID: 1725664
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Viral safety of intravenous immunoglobulins G for therapeutic use].
    Burnouf-Radosevich M
    Transfus Clin Biol; 1995; 2(3):167-79. PubMed ID: 7627356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transmission of viral infections through intravenous immune globulin.
    Schiff RI
    N Engl J Med; 1994 Dec; 331(24):1649-50. PubMed ID: 7969346
    [No Abstract]   [Full Text] [Related]  

  • 53. [An enhanced viral safety of blood preparations].
    Zhiburt EB
    Vopr Virusol; 2004; 49(4):46-8. PubMed ID: 15293512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Industrial pasteurization of plasma and criteria of quality].
    Burnouf-Radosevich M; Burnouf T; Huart JJ
    Rev Fr Transfus Hemobiol; 1993 Jan; 36(1):93-102. PubMed ID: 8476493
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donor safety in plasmapheresis.
    Lundsgaard-Hansen P
    Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancement in the safety of immune globulins prepared from high-risk plasma.
    Gao F; Prince AM; Pascual D; Horowitz B
    Vox Sang; 1993; 64(4):204-9. PubMed ID: 8390765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis C and immune globulin.
    López-Jiménez J; Odriozola J; Pérez-Oteyza J; García-Laraña J
    N Engl J Med; 1995 May; 332(18):1235-6. PubMed ID: 7700324
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis C and immune globulin.
    Prince AM; Horowitz B
    N Engl J Med; 1995 May; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis C and immune globulin.
    Douglas SD; Slade HB
    N Engl J Med; 1995 May; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
    [No Abstract]   [Full Text] [Related]  

  • 60. Clinical safety of intravenous immune globulin and freedom from transmission of viral disease.
    Rousell RH
    J Hosp Infect; 1988 Aug; 12 Suppl D():17-27. PubMed ID: 2902125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.